TITLE

Trichuris suis therapy In Croh's disease

AUTHOR(S)
Summers, R. W.; Elliott, D. E.; Urban Jr, J. F.; Thompson, R.; Weinslock, J. V.
PUB. DATE
January 2005
SOURCE
Gut;Jan2005, Vol. 54 Issue 1, p87
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Crohn's disease is common in highly industrialised Western countries where helminths ore rare and uncommon in less developed areas of the world where most people carry worms. Helminths diminish immune responsiveness in naturally colonised humans and reduce inflammation in experimental colitis. Thus exposure to helminths may help prevent or even ameliorate Crohn's disease. Aims: The aim of the study was to determine the safety and possible efficacy of the intestinal helminth Trichuris suis in the treatment of patients with active Crohn's disease. Patients: Twenty nine patients with active Crohn's disease, defined by a Crohn's disease activity index (CDAI) ⩾220 were enrolled in this open label study. Methods: All patients ingested 2500 live T suis ova every three weeks for 24 weeks, and disease activity was monitored by CDAI. Remission was defined as a decrease in CDAI to less than 150 while a response was defined as a decrease in CDAI of greater than 100. Results: At week 24, 23 patients (79.3%) responded (decrease in CDAI >100 points or CDAI <150) and 2 1/29 (72.4%) remitted (CDAI <150). Mean CDAI of responders decreased 177.1 points below baseline. Analysis at week 12 yielded similar results. There were no adverse events. Conclusions: This new therapy may offer a unique, safe, and efficacious alternative for Crohn's disease management. These findings also support the premise that natural exposure to helminths such as T suis affords protection from immunological diseases like Crohn's disease.
ACCESSION #
16163229

 

Related Articles

  • Crohn's Disease of the Colon IV. CLINICAL FEATURES OF CROHN'S (ILEO) COLITIS. Greenstein, Adrian J.; Geller, Stephen A.; Dreiling, Reiling; Aufses Jr., Arthur H. // American Journal of Gastroenterology;Sep1975, Vol. 64 Issue 3, p191 

    Presents information on Crohn's disease of the colon. Reason for the lag period in the universal recognition of Crohn's colitis as a clinical entity; Diagnostic features of Crohn's colitis; Incidence of clinical features in patients with colitis and ileocolitis.

  • Characterization of Inflammatory Bowel Disease With Urinary Metabolic Profiling. Williams, Horace R. T.; Cox, I. Jane; Walker, David G.; North, Bernard V.; Patel, Venisha M.; Marshall, Sara E.; Jewell, Derek P.; Ghosh, Subrata; Thomas, Huw J. W.; Teare, Julian P.; Jakobovits, Simon; Zeki, Sebastian; Welsh, Kenneth I.; Taylor-Robinson, Simon D.; Orchard, Timothy R. // American Journal of Gastroenterology;Jun2009, Vol. 104 Issue 6, p1435 

    OBJECTIVES:Distinguishing between the inflammatory bowel disease (IBD), Crohn's disease (CD), and ulcerative colitis (UC) is important for both management and prognostic reasons. Discrimination using noninvasive techniques could be an adjunct to conventional diagnostics. Differences have been...

  • An incidental enterocolic lymphocytic phlebitis pattern is seen commonly in the rectal stump of patients with diversion colitis superimposed on inflammatory bowel disease. R Chetty // Journal of Clinical Pathology;May2009, Vol. 62 Issue 5, p464 

    AIMS: Enterocolic lymphocytic phlebitis (ELP) is an uncommon cause of bowel pathology and most frequently results in ischaemia. It is characterised by an artery-sparing, venulocentric lymphoid infiltrate that causes a phlebitis and vascular compromise. Rare cases of ELP have been encountered...

  • Reduced hydrophobicity of the colonic mucosal surface in ulcerative colitis as a hint at a physicochemical barrier defect. Braun, Annika; Schönfeld, Ulrike; Welsch, Thilo; Kadmon, Martina; Funke, Benjamin; Gotthardt, Daniel; Zahn, Alexandra; Autschbach, Frank; Kienle, Peter; Zharnikov, Michael; Grunze, Michael; Stremmel, Wolfgang; Ehehalt, Robert // International Journal of Colorectal Disease;Aug2011, Vol. 26 Issue 8, p989 

    Purpose: There is increasing evidence that a defect of the gastrointestinal mucosal barrier is important for the development of inflammatory bowel diseases (IBD). The hydrophobicity of the colonic mucosal surface is a measure of its resistance to luminal antigens, e.g. of bacterial origin....

  • Crohn's Disease of the Colon III. Toxic Dilatation of the Colon in Crohn's Colitis. Greenstein, Adrian J.; Kark, Allan E.; Dreiling, David A. // American Journal of Gastroenterology;Feb1975, Vol. 63 Issue 2, p117 

    Presents a study on the occurrence of toxic dilatation of the colon in Crohn's colitis. Conservative measures that will result to toxic dilatation; Description of the toxic dilatation of the colon or toxic megacolon; Diagnosis of Crohn's disease; Management techniques for treating patient with...

  • Malignancy in Crohn's Disease. Bernstein, David; Rogers, Arvey // American Journal of Gastroenterology;Mar1996, Vol. 91 Issue 3, p434 

    The risk for the development of malignancy in Crohn's disease is not as well defined as it is with ulcerative colitis. The risk for the development of small bowel adenocarcinoma is greater in patients with Crohn's disease than in the general population although the magnitude of this increased...

  • Universal Colitis. Ho, Ricky Y.; Thomas, Eapen; Pitchumoni, C. S. // American Journal of Gastroenterology;May1978, Vol. 69 Issue 5, p601 

    Presents a case study which focused on a 34-year old African American male diagnosed with Crohn's colitis. Symptoms experienced by the patient; Results of physical examination; Complications of barium enema discovered in the patient.

  • A toddler with recurrent oral and genital ulcers. Yüksel, Zehre; Schweizer, Joachim J.; Mourad-Baars, Petronella E. C.; Sukhai, Ram N.; Mearin, Luisa M. // Clinical Rheumatology;Jun2007, Vol. 26 Issue 6, p969 

    In western countries, when a child presents with recurrent oral ulcers and colitis, the diagnosis of Crohn’s disease is mostly made. In our patient, the diagnosis was Behçet’s disease with gastrointestinal manifestations. Behçet’s disease with gastrointestinal...

  • Direct hit. Wagner, Siobhan // Engineer (00137758);12/8/2008, Vol. 293 Issue 7762, p33 

    The article reports on the importance of iPill for people suffering from serious intestinal disorders such as Crohn's Disease, colitis and cancer of the colon. As stated, the iPill which is still in prototype form was developed by Philips Reseach which claims that it took camera pill technology...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics